Lhteenvuo M, Tiihonen J, Solismaa A, et al
Most patients experience rapid symptom relief and can return to normal activities within a few days
BPC-157 has an extremely short plasma half-life - approximately 4 minutes after intravenous administration in rats - although downstream effects persist for hours to days
The compound works through the same NNMT inhibition mechanism in both sexes, though dosing may need adjustment based on body weight
Prajapati, extends his sincere appreciation to the Faculty of Pharmacy, Silpakorn University, Thailand, for their generous financial support that enabled the completion of this work
Pediatrics, 145 (1), Article e20193447